Are apatite nanoparticles safe?

Lancet

Volumn 369, Issue 9579, 2007, Pages 2078-

  Ciftcioglu, Neva ^a,c   Aho, Katja M ^b   McKay, David S ^a   Kajander, E Olavi ^b,c  

^a NASA JOHNSON SPACE CENTER   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Nanobac Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; IMMUNOGLOBULIN G; NANOMATERIAL; NANOPARTICLE;

BIOSAFETY; BLOOD CELL COUNT; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; SAFETY;

EID: 34250644935     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60977-5     Document Type: Letter

References (5)

1. The Lancet. The risks of nanotechnology for human health. Lancet 369 (2007) 1142
2. Bergamaschi E., Bussolati O., Magrini A., et al. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment. Int J Immunopathol Pharmacol 19 suppl 4 (2006) 3-10
3. Dalbeth N., and Haskard D. Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol 17 (2005) 314-318
4. Marmur E., Phelps R., and Goldberg D. Clinical, histologic and electron microscopic findings after injection of hydroxyapatite filler. J Cosmet Laser Ther 6 (2004) 223-226
5. Kajander E., and Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95 (1998) 8274-8279